Hongtao Jia
Shanghai, 200233, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Scleraxis-expressing progenitor cells are critical for the maturation of the annulus fibrosus and demonstrate therapeutic potential.
Journal: Journal of orthopaedic translation
Published: November 13, 2024
ACACB is a novel metabolism-related biomarker in the prediction of response to cetuximab therapy inmetastatic colorectal cancer.
Journal: Acta biochimica et biophysica Sinica
Published: September 16, 2022
Comprehensive exploration of tumor immune microenvironment feature and therapeutic response in colorectal cancer based on a novel immune-related long non-coding RNA prognostic signature.
Journal: Frontiers in genetics
Published: June 15, 2022
LncRNA LENGA acts as a tumor suppressor in gastric cancer through BRD7/TP53 signaling.
Journal: Cellular and molecular life sciences : CMLS
Published: June 02, 2022
Genomic signature of MTOR could be an immunogenicity marker in human colorectal cancer.
Journal: BMC cancer
Published: January 12, 2022
Comprehensive Analysis of Ferroptosis-Related Markers for the Clinical and Biological Value in Gastric Cancer.
Journal: Oxidative medicine and cellular longevity
Published: August 09, 2021
CAMTA1-PPP3CA-NFATc4 multi-protein complex mediates the resistance of colorectal cancer to oxaliplatin.
Journal: Cell death discovery
Published: August 04, 2021
An Original Ferroptosis-Related Gene Signature Effectively Predicts the Prognosis and Clinical Status for Colorectal Cancer Patients.
Journal: Frontiers in oncology
Published: May 19, 2021
NDRG1 enhances the sensitivity of cetuximab by modulating EGFR trafficking in colorectal cancer.
Journal: Oncogene
Published: February 15, 2021
NDRG1 regulates Filopodia-induced Colorectal Cancer invasiveness via modulating CDC42 activity.
Journal: International journal of biological sciences
Published: December 02, 2020
Artificial Intelligence in Decision-Making for Colorectal Cancer Treatment Strategy: An Observational Study of Implementing Watson for Oncology in a 250-Case Cohort.
Journal: Frontiers in oncology
Published: August 12, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026